Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Pathea Bruno,
No information about this author
Aneeta Arshad,
No information about this author
Maria-Raluca Gogu
No information about this author
et al.
Life,
Journal Year:
2025,
Volume and Issue:
15(1), P. 126 - 126
Published: Jan. 18, 2025
Post-translational
modifications
(PTMs)
of
proteins
dynamically
build
the
buffering
and
adapting
interface
between
oncogenic
mutations
environmental
stressors,
on
one
hand,
cancer
cell
structure,
functioning,
behavior.
Aberrant
PTMs
can
be
considered
as
enabling
characteristics
long
they
orchestrate
all
malignant
variability
in
proteome
cells,
cancer-associated
tumor
microenvironment
(TME).
On
other
enhance
anticancer
mechanisms
tumoral
ecosystem
or
sustain
beneficial
effects
oncologic
therapies
through
degradation
inactivation
carcinogenic
or/and
activation
tumor-suppressor
proteins.
In
this
review,
we
summarized
analyzed
a
wide
spectrum
involved
regulatory
that
drive
tumorigenesis,
genetic
instability,
epigenetic
reprogramming,
events
metastatic
cascade,
cytoskeleton
extracellular
matrix
(ECM)
remodeling,
angiogenesis,
immune
response,
tumor-associated
microbiome,
metabolism
rewiring
most
important
hallmarks
cancer.
All
develop
due
to
proteins,
which
modulate
gene
transcription,
intracellular
signaling,
protein
size,
activity,
stability
localization,
trafficking,
secretion,
half-life,
protein–protein
interactions
(PPIs).
associated
with
exploited
better
understand
underlying
molecular
heterogeneous
chameleonic
disease,
find
new
biomarkers
progression
prognosis,
personalize
oncotherapies,
discover
targets
for
drug
development.
Language: Английский
Recent update on the Development of HPV16 inhibitors for Cervical Cancer
Critical Reviews in Oncology/Hematology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 104703 - 104703
Published: March 1, 2025
Language: Английский
Targeting the interplay between human papillomavirus oncoproteins and hedgehog signaling: assessment of chemopreventive potential of carvacrol in cervical cancer
3 Biotech,
Journal Year:
2025,
Volume and Issue:
15(4)
Published: March 5, 2025
Language: Английский
Astragalin inhibits the proliferation of high-risk HPV-positive cervical epithelial cells and attenuates malignant cervical lesions
Cytotechnology,
Journal Year:
2025,
Volume and Issue:
77(3)
Published: March 19, 2025
Language: Английский
The HPV101 E7 protein shares host cellular targets and biological activities with high-risk HPV16 E7
Maya K. Gelbard,
No information about this author
Miranda Grace,
No information about this author
Annika von Schoeler-Ames
No information about this author
et al.
Tumour Virus Research,
Journal Year:
2024,
Volume and Issue:
unknown, P. 200300 - 200300
Published: Dec. 1, 2024
Human
papillomaviruses
(HPVs)
are
a
diverse
family
of
viruses
with
over
450
members
that
have
been
identified
and
fully
sequenced.
They
classified
into
five
phylogenetic
genera:
alpha,
beta,
gamma,
mu,
nu.
The
high-risk
alpha
HPVs,
such
as
HPV16,
studied
the
most
extensively
due
to
their
medical
significance
cancer-causing
agents.
However,
while
nearly
70%
all
HPVs
gamma
genus,
they
almost
entirely
unstudied.
This
is
because
considered
medically
irrelevant
commensals
them
infect
skin
not
known
cause
significant
clinical
lesions
in
immunocompetent
individuals.
Members
6
however,
detected
anogenital
tract
mucosa
HPV101
has
isolated
from
premalignant
cervical
lesion.
Moreover,
unique
genome
structure.
lack
E6
proteins
but
place
E6,
encode
unique,
tiny
hydrophobic
without
any
close
viral
or
cellular
homologs
termed
E10.
Here
we
report
E7
shares
biochemical
activities
HPV16
E7,
including
ability
target
pRB
PTPN
tumor
suppressor
for
degradation.
study
underscores
importance
further
characterizing
other
unstudied
HPV
species.
Language: Английский